Barclays
TTHI

Barclays’s TRANSITION THERAPEUTICS INC (CANADA) TTHI Stock Holding History

Barclays’s Portfolio TTHI Stock Details TTHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-700
Closed -$3K – 8012
2013
Q3 		$3K Buy
+700
New +$2.76K ﹤0.01% 7164

Other funds holding TTHI

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VC
Vestor Capital Chicago, Illinois $1.59M AUM 51.04% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return

Barclays's TTHI Position: Q4 2013 in Review

Barclays sold out of TRANSITION THERAPEUTICS INC (CANADA) (TTHI) in Q4 2013, closing a stake of 700 shares — an estimated $3K sold.

Barclays first reported a position in TTHI in Q3 2013 and held it in 1 quarter. The position peaked at $3K in Q3 2013. 21 funds tracked by Wall St. Rank hold TTHI as of Q4 2013.

  • Barclays reported no remaining TRANSITION THERAPEUTICS INC (CANADA) position as of Q4 2013 after selling out during the quarter.
  • Barclays sold 700 TRANSITION THERAPEUTICS INC (CANADA) shares in Q4 2013, an estimated $3K.
  • Barclays first reported a position in TRANSITION THERAPEUTICS INC (CANADA) in Q3 2013 and held it in 1 quarter.
  • Barclays's TRANSITION THERAPEUTICS INC (CANADA) position peaked at $3K in Q3 2013.
  • 21 funds tracked by Wall St. Rank held TRANSITION THERAPEUTICS INC (CANADA) as of Q4 2013.

Based on Barclays's 13F filing for Q4 2013, filed 13 Feb 2014.